Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
References A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of Bimagrumab and Tirzepatide, Alone or in Combination, to Investigate the Efficacy and Safety in Adult Participants With Obesity or Overweight Without Type 2 Diabetes
The US alone accounts for well over half of global GLP-1 sales, given that North America represents about 77% of worldwide GLP-1 revenues and the US makes up the lions share of that market
For global availability context once approval lands, see our retatrutide availability guide
This triple mechanism produced 24.2% mean weight reduction in Phase 2 trials, exceeding both comparators
Liposomal delivery is designed to protect the nutrient as it travels through your digestive system
US$ 28.96
US$ 28.16
US$ 29.83
